Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant

Joshua Allen, Ana Lucia Ruano Mendez, Lisa Rybicki, Yazeed Sawalha  , Deepa Jagadeesh, Robert Dean, Brad Pohlman, Mitchell R. Smith, Eric D. Hsi, Brian T. Hill
  • Therapeutic Advances in Hematology, March 2018, SAGE Publications
  • DOI: 10.1177/2040620718759249

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1177/2040620718759249

In partnership with: